Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Blue Owl Capital Holdings LP
Form 13F · Q2 2026

Blue Owl Capital Holdings LP

CIK 1858703Filed 2026-08-1113F-HR View the filing on EDGAR ↗
$665M
Reported book value
76
Positions
12
Quarters on record
Top 50
Positions

Blue Owl Capital Holdings LP — holdings

Top 50 positions of 76, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1SPCX Space Exploration Techn Corp1.4M—$239M36.0%
2AKTS Aktis Oncology Inc3.1M−2.9%$99M14.9%
3CGEM Cullinan Therapeutics Inc1.5M−19.4%$28M4.2%
4LRMR Larimar Therapeutics Inc9.2M+28.7%$28M4.2%
5NCDL Nuveen Churchill Direct Lend2.1M+0.0%$27M4.0%
6MPLT Maplight Therapeutics Inc729,929−27.4%$26M3.9%
7CAPITAL ONE FINL CORP Capital One Finl Corp119,757—$24M3.6%
8BLUE OWL CAPITAL CORPORATION Blue Owl Capital Corporation2.0M+0.0%$22M3.3%
9FISN Deep Fission Inc1.3M—$15M2.2%
10DELL Dell Technologies Inc32,961+137.1%$14M2.1%
11HLLY Holley Inc4.4M+3.3%$11M1.7%
12EYPT Eyepoint Inc762,594−16.4%$11M1.6%
13SGMT Sagimet Biosciences Inc1.3M+277.5%$10M1.5%
14CRVS Corvus Pharmaceuticals Inc608,600+11.7%$9M1.4%
15ARTV Artiva Biotherapeutics Inc874,542—$8M1.3%
16CMPX Compass Therapeutics Inc3.6M+23.2%$8M1.2%
17CNDT Conduent Inc5.0M+0.0%$7M1.1%
18RYTM Rhythm Pharmaceuticals Inc61,455+0.0%$7M1.0%
19CMPS Compass Pathways Plc450,000—$6M1.0%
20RARE Ultragenyx Pharmaceutical In182,638−39.7%$6M0.9%
21PVLA Palvella Therapeutics Inc Ne36,259+16.0%$6M0.8%
22IMA Imagenebio Inc917,692−4.3%$5M0.8%
23VRDN Viridian Therapeutics Inc260,000—$5M0.7%
24IMMX Immix Biopharma Inc437,552−20.1%$5M0.7%
25ORIC Oric Pharmaceuticals Inc400,000+166.7%$4M0.7%
26LENZ Lenz Therapeutics Inc756,722+49.3%$4M0.6%
27AQST Aquestive Therapeutics Inc942,932−30.0%$4M0.6%
28STARWOOD PPTY TR INC Starwood Ppty Tr Inc196,355+23.8%$3M0.5%
29EVMN Evommune Inc180,000+80.0%$2M0.4%
30ELDN Eledon Pharmaceuticals Inc566,509−60.1%$2M0.3%
31CABA Cabaletta Bio Inc714,710—$2M0.3%
32CHIME FINL INC Chime Finl Inc89,878—$2M0.3%
33CNTX Context Therapeutics Inc2.9M−42.3%$2M0.2%
34WW INTL INC Ww Intl Inc84,399−11.7%$1M0.2%
35MRKR Marker Therapeutics Inc554,250+0.0%$814,7480.1%
36ADCT Adc Therapeutics Sa733,568+0.0%$784,9180.1%
37CYBIN INC Cybin Inc59,911—$396,0120.1%
38FLD Fold Hldgs Inc856,632+0.0%$385,4840.1%
39NIOCORP DEVS LTD Niocorp Devs Ltd268,280−16.2%$380,9580.1%
40RZLV Rezolve Ai Plc235,121+0.0%$213,9600.0%
41BNAI Brand Engagement Network Inc1.5M−12.8%$203,5330.0%
42PIPR Piper Sandler Companies2,428+0.0%$175,6420.0%
43ENGN Engene Therapeutics Inc511,177—$148,1900.0%
44CELC Celcuity Inc1,249—$130,6700.0%
45USDE Stablecoinx Inc250,000—$102,5000.0%
46ET Energy Transfer L P5,326+0.0%$101,8330.0%
47CAI Caris Life Sciences Inc4,711+0.0%$83,9500.0%
48VOD Vodafone Group Plc5,371—$71,0050.0%
49DAVE INC Dave Inc28,750+0.0%$68,4250.0%
50MURANO GLOBAL INVT PLC Murano Global Invt Plc261,875—$62,8500.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.